![Jasmine [colour].jpg](https://static.wixstatic.com/media/2c5d56_0874112aada14b5fa7ee84b44ebd8b0d~mv2.jpg/v1/crop/x_1441,y_31,w_2518,h_3519/fill/w_484,h_664,al_c,q_80,usm_0.66_1.00_0.01,enc_avif,quality_auto/Jasmine%20%5Bcolour%5D.jpg)
Jasmine Schipp
PhD
​
I work as a Policy Analyst at the Australian Academy of Science, where I collaborate with leading scientists, colleagues, government, and industry to shape science and public policy priorities in Australia.
I have a background in health and psychology research. In my previous role, I developed evidence-based guidelines for women's health. My PhD explored the experiences of people with type 1 diabetes using open-source, user-developed health technology. I have worked on research in developmental neuroscience and child neuropsychology, as well as studies on injectable medication use (e.g. Ozempic, insulin) among adults with type 2 diabetes.​
​
​
​
SELECTED PEER REVIEWED PUBLICATIONS
Braune K, Gajewska KA, Thieffry A, Lewis DM, Froment T, O'Donnell S, Speight J, Hendrieckx C, Schipp J, Skinner TC, Langstrup H, Tappe A, Raile K, Cleal B. (2021). Why #WeAreNotWaiting - motivations and self-reported outcomes among users of open-source automated insulin delivery systems: a multinational survey. Journal of Medical Internet Research, 23(6):e25409
Holmes-Truscott E, Schipp J, Dunning T, Furler J, Hagger V, Holloway EE, Manski-Nankervis J-A, Shaw JE, Skinner TC, Speight J. (2022). “For me, it didn’t seem as drastic a step as being controlled by insulin”: A qualitative investigation of expectations and experiences of non-insulin injectable therapy among adults with type 2 diabetes. Diabetic Medicine, 39(2), e14681.
Holmes-Truscott, E., Schipp, J., Cooke, D.D. et al. (2024). Perceptions of adults with type 1 diabetes toward diabetes-specific quality of life measures: a survey-based qualitative exploration. Health and Quality of Life Outcomes, 22(1), 70.
Schipp J, Skinner TC, Holloway EE, Scibilia R, Langstrup H, Speight J, Hendrieckx C. (2021). How adults with type 1 diabetes are navigating the challenges of open-source artificial pancreas systems: a qualitative study. Diabetes Technology & Therapeutics, 23(8):546-554
Schipp J, Skinner TC, Holloway EE, Scibilia R, Langstrup H, Speight J, Hendrieckx C. (2022). ‘We’re all on the same team’. Perspectives on the future of artificial pancreas systems by adults in Australia with type 1 diabetes using open-source technologies: A qualitative study. Diabetic Medicine, 39(5), e14708.
Schipp, J., Hendrieckx, C., Braune, K., Knoll, C., O’Donnell, S., Ballhausen, H., ... & Speight, J. (2023). Psychosocial Outcomes Among Users and Nonusers of Open-Source Automated Insulin Delivery Systems: Multinational Survey of Adults With Type 1 Diabetes. Journal of Medical Internet Research, 25, e44002.
SELECTED PEER REVIEWED PRESENTATIONS
PsychoSocial Aspects of Diabetes (PSAD): Online Event; 20-22 October 2021
Schipp J, Skinner TC, Holloway E, Scibilia R, Langstrup H, Speight J, Hendrieckx C. “We’re all on the same team”: perspectives on the future of artificial pancreas systems by adults with type 1 diabetes using open-source technologies. (ORAL PRESENTATION)
Chronic Living - An International Conference: Online Event; 4-6 March 2021
Schipp J. Experiences of Building and Using DIY Diabetes Technology by Early Adopters in Australia. (ORAL PRESENTATION)
Australasian Diabetes Congress (ADC): Online Event; 11-13 November 2020
Schipp J, Skinner TC, Holloway EE, Scibilia R, Langstrup H, Speight J, Hendrieckx C. Navigating the challenges of open-source artificial pancreas systems: a qualitative study. (E-POSTER)
Advanced Technologies & Treatments for Diabetes (ATTD): Madrid, Spain; 19-22 February 2020
Schipp J, Speight J, Holloway E, Scibilia R, Langstrup H, Skinner TC, Hendrieckx C. Experiences of user-led diabetes technologies among Australian adults with type 1 diabetes (POSTER) (VIDEO) (PUBLISHED ABSTRACT)